Valeant eyeing merger but smaller buys more likely now -CEO

May 28 (Reuters) - Valeant Pharmaceuticals International Inc continues to have discussions about a potential "merger of equals," but cannot predict the timing, Chief Executive Michael Pearson said on Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.